Autopsy report · NCT04316481
IDE-ALERTS Continued Access Study
Cause of deathFunding or business, also regulatory or ethics
“FDA Approval was received for the Model AMSG3-E IMD and therefore commercial implants could be started. There was no longer any need to implant under the CAS. CAS patients were transitioned to commercial patients.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 4 months before it stopped.
- 17 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Angel Medical Systems
- Sponsor type
- Industry
- Conditions
- Acute Coronary Syndrome
- Interventions
- AngelMed Guardian System
- Participants
- 17
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.